Endogenous Erythropoietin and Outcome in Heart Failure

Effects of erythropoietin after an acute myocardial infarction: Rationale and study design of a prospective, randomized, clinical trial (HEBE III)

(2008) Anne M. Belonje et al.   AMERICAN HEART JOURNAL

Erythropoietin levels in heart failure after an acute myocardial infarction: Determinants, prognostic value, and the effects of captopril versus losartan

(2008) Anne M.S. Belonje et al.   AMERICAN HEART JOURNAL

Effect of Moderate or Intensive Disease Management Program on Outcome in Patients With Heart FailureCoordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)

(2008) Tiny Jaarsma   ARCHIVES OF INTERNAL MEDICINE

Erythropoietin Stimulates Normal Endothelial Progenitor Cell-Mediated Endothelial Turnover, but Attributes to Neovascularization Only in the Presence of Local Ischemia

(2008) B. Daan Westenbrink et al.   CARDIOVASCULAR DRUGS AND THERAPY

Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients

(2008) P. van der Meer et al.   EUROPEAN HEART JOURNAL

Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit

(2008) Erik Lipšic et al.   EUROPEAN JOURNAL OF HEART FAILURE

Anemia and Chronic Heart Failure

(2008) Inder S. Anand   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hemoglobin Level Variability: Associations with Mortality

(2007) D. T. Gilbertson et al.   Clinical Journal of the American Society of Nephrology